Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Gamma Hydroxybutyric Acid in Alcohol-dependence Treatment Efficacy (GATE) I Trial: a Comparative Study Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome

NCT02090504 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.

NCT NCT02090504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Gamma Hydroxybutyric Acid in Alcohol-dependence Treatment Efficacy (GATE) I Trial: a Comparative Study Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome
Lead sponsor
Catholic University of the Sacred Heart
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2002
Completion date
May 31, 2009
Enrollment
127 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol withdrawal syndrome